Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart ...
The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep ...
The medication also promotes weight loss, with patients losing an average ... options and eligibility for savings programs. The FDA's approval of Zepbound provides a new approach to treatment ...
called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weight loss and has been shown to reduce apnea events." ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec ... “Zepbound promotes weight loss and has been shown to reduce apnea ...
The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription ...
The Food and Drug Administration approved Eli Lilly’s ... the condition by reducing body weight, according to the FDA. The move comes as weight-loss medications have garnered immense national ...